Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review

Cerebral small vessel disease (SVD) pathophysiology is poorly understood. Cerebrovascular reactivity (CVR) impairment may play a role, but evidence to date is mainly indirect. Magnetic resonance imaging (MRI) allows investigation of CVR directly in the tissues affected by SVD. We systematically reviewed the use of MRI to measure CVR in subjects with SVD. Five studies (total n = 155 SVD subjects, 84 controls) provided relevant data. The studies included different types of patients. Each study used blood oxygen level dependent (BOLD) MRI to assess CVR but a different vasoactive stimulus and method of calculating CVR. CVR decreased with increasing white matter hyperintensities in two studies (n = 17, 11%) and in the presence of microbleeds in another. Three studies (n = 138, 89%) found no association of CVR with white matter hyperintensities. No studies provided tissue-specific CVR values. CVR decreased with age in three studies, and with female gender and increasing diastolic blood pressure in one study. Safety and tolerability data were limited. Larger studies using CVR appear to be feasible and are needed, preferably with more standardized methods, to determine if specific clinical or radiological features of SVD are more or less associated with impaired CVR.

[1]  C. Sudlow,et al.  Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. , 2005, Brain : a journal of neurology.

[2]  David J Mikulis,et al.  Mapping Cerebrovascular Reactivity Using Blood Oxygen Level-Dependent MRI in Patients With Arterial Steno-occlusive Disease: Comparison With Arterial Spin Labeling MRI , 2008, Stroke.

[3]  O Henriksen,et al.  Functional MRI of CO2 induced increase in cerebral perfusion , 1994, NMR in biomedicine.

[4]  Kirsten Shuler,et al.  A Systematic Review of Dynamic Cerebral and Peripheral Endothelial Function in Lacunar Stroke Versus Controls , 2010, Stroke.

[5]  David J Mikulis,et al.  CO2 blood oxygen level-dependent MR mapping of cerebrovascular reserve in a clinical population: safety, tolerability, and technical feasibility. , 2013, Radiology.

[6]  Michael Germuska,et al.  Comparison of CO2 in Air Versus Carbogen for the Measurement of Cerebrovascular Reactivity with Magnetic Resonance Imaging , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  Jinsoo Uh,et al.  Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease , 2012, Neurobiology of Aging.

[8]  D J Mikulis,et al.  Measuring cerebrovascular reactivity: what stimulus to use? , 2013, The Journal of physiology.

[9]  Peter R. Luijten,et al.  Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity — A 7T study , 2012, NeuroImage.

[10]  Frédérique Frouin,et al.  Hearts and minds: linking vascular rigidity and aerobic fitness with cognitive aging , 2015, Neurobiology of Aging.

[11]  Yuehui Tao,et al.  A systematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research , 2012, European Radiology.

[12]  Peiying Liu,et al.  Cerebrovascular Reactivity in the Brain White Matter: Magnitude, Temporal Characteristics, and Age Effects , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[14]  Hugh S Markus,et al.  Risk factor profile of cerebral small vessel disease and its subtypes , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  Sven Haller,et al.  Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease , 2015, Neurobiology of Aging.

[16]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[17]  David G. Norris,et al.  Determination of Cerebrovascular Reactivity by Means of fMRI Signal Changes in Cerebral Microangiopathy: A Correlation with Morphological Abnormalities , 2003, Cerebrovascular Diseases.

[18]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[19]  Martijn Froeling,et al.  Investigating the non-linearity of the BOLD cerebrovascular reactivity response to targeted hypo/hypercapnia at 7T , 2014, NeuroImage.

[20]  C. Sudlow,et al.  Pathology of Lacunar Ischemic Stroke in Humans—A Systematic Review , 2012, Brain pathology.

[21]  W. M. van der Flier,et al.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  R. Hoge,et al.  Comparison of Cerebral Vascular Reactivity Measures Obtained Using Breath-Holding and CO2 Inhalation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  I. Deary,et al.  Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities , 2014, Neurology.

[24]  P. Hofman,et al.  Mapping hypercapnia-induced cerebrovascular reactivity using BOLD MRI , 2005, Neuroradiology.

[25]  Oliver Speck,et al.  Blood Oxygen Level–Dependent MRI of Cerebral CO2 Reactivity in Severe Carotid Stenosis and Occlusion , 2005, Stroke.

[26]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[27]  Y. Hsu,et al.  Breathhold‐regulated blood oxygenation level‐dependent (BOLD) MRI of human brain at 3 tesla , 2010, Journal of Magnetic Resonance Imaging.

[28]  I. Deary,et al.  Total MRI load of cerebral small vessel disease and cognitive ability in older people , 2015, Neurobiology of Aging.

[29]  D. Werring,et al.  The Microbleed Anatomical Rating Scale (MARS) , 2009, Neurology.